Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.
Svaton M, Zemanova M, Zemanova P, Kultan J, Fischer O, Skrickova J, Jakubikova L, Cernovska M, Hrnciarik M, Jirousek M, Krejci J, Krejci D, Bilek O, Blazek J, Hurdalkova K, Barinova M, Melichar B.
Svaton M, et al. Among authors: melichar b.
Anticancer Res. 2020 Apr;40(4):2209-2217. doi: 10.21873/anticanres.14182.
Anticancer Res. 2020.
PMID: 32234916